A5014806250- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac Structural Anomalies and Repair
- Pulmonary Hypertension Research and Treatments
- Mechanical Circulatory Support Devices
- Cardiac tumors and thrombi
- Venous Thromboembolism Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Vascular Procedures and Complications
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Transplantation: Methods and Outcomes
- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Cerebrovascular and Carotid Artery Diseases
- Cardiac and Coronary Surgery Techniques
- Heart Rate Variability and Autonomic Control
- Mesenchymal stem cell research
- Acute Ischemic Stroke Management
Silesian Center for Heart Disease
2016-2025
Medical University of Silesia
2007-2025
Laboratoire Informatique d'Avignon
2022
Liverpool Heart and Chest Hospital
2022
University of Liverpool
2022
Kardio-Med Silesia
2007-2021
Shahid Beheshti University of Medical Sciences
2016
Medical University of Lublin
2016
Pontificia Universidad Católica de Chile
2016
Centar za Promociju Nauke
2016
For patients with functional mitral regurgitation (FMR) and symptomatic heart failure (HF), randomized trials of transcatheter edge-to-edge repair (M-TEER) have produced conflicting results.
Lipid disorders are the most common risk factor for ASCVD in Poland, where it is responsible up to 200,000 deaths/year, with number of MI and strokes reaching 80,000 annually 25% people dying within 3 years after MI. The level control LDL-C low, at only about 20% among high- very high-risk patients who often require combination LLT a potent statin ezetimibe. Moreover, even as many several million concomitant antiplatelet (acetylsalicylic acid) therapy view their risks indications. SPC...
Objective Left atrial appendage (LAA) thrombus has heretofore been considered a contraindication to percutaneous LAA closure (LAAC). Data regarding its management are very limited. The aim of this study was analyse the medical and invasive treatment patients referred for LAAC in presence thrombus. Methods This multicentre observational registry included 126 consecutive with on preprocedural imaging. Treatment strategies intensification antithrombotic therapy (IAT) or direct LAAC. primary...
Introduction: Iatrogenic atrial septal defect (iASD) resulting from MitraClip procedures may cause volume overload and deterioration of right ventricular (RV) function. The concurrent procedure, along with an intervention to close iASD appears yield a potentially favorable impact on the functioning ventricle. Aim study: study aims evaluate effect closure occluder immediately after procedure RV function, pulmonary resistance, ventricle-pulmonary artery coupling (RV-PAc). Methods: group (ASDc)...
Effective ECG monitoring to detect silent atrial fibrillation 1 patients with AF/AFL. 1,2Although the incidence of AF/AFL is high, methods used diagnose AF/AFL, especially in clinically AF (SAF) are still expensive, and therefore their routine use medical practice limited. 3INTRODUCTION Atrial (AF) flutter (AFL) most common arrhythmias worldwide increases age.Stroke, heart failure, increased mortality serious complications
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with heart failure (HF), lowered LV ejection fraction, wide QRS. However, many (< or =40%) do not respond to this form of pacing. TRUST CRT is a prospective, single-center, randomized, single-blind, parallel, controlled study that has been designed treat moderate severe HF (NYHA III-IV), QRS > =120 ms, sinus rhythm, dysfunction (EF < = 35%), signs mechanical dyssynchrony.The primary objective will evaluate...
Background: Silent atrial fibrillation (SAF) is common and associated with poor outcomes. Aims: to study the risk factors for AF SAF in elderly (≥65 years) general population develop a stratification model predicting SAF. Methods: Continuous ECG monitoring was performed up 30 days using vest-based system cohort from NOMED-AF, cross-sectional based on nationwide sample. The independent were determined multiple logistic regression. ROC analysis applied validate developed score. Results: From...
Background: The benefits of oral anticoagulation (OAC) therapy are undeniable. However, such treatment is contraindicated in 2%–10% patients. According to the latest guidelines, percutaneous left atrial appendage occlusion (LAAO) may be considered stroke prevention. Aims: We analyzed data patients from Polish population, who had undergone LAAO procedures Silesian Province based on limited reports. Methods: SILCARD database all underwent between 2006 and 2019, databases centers performing...
Pulmonary vein isolation with cryoballoon catheter ablation (CCB) is an effective method of treatment in patients atrial fibrillation (AF), but heart failure (HF) the role CCB remains unknown.The aim study was to assess feasibility, effectiveness, and safety HF cardiac im-plantable electronic devices (CIEDs), impact procedure on symptoms, echocardiographic parameters.Thirty consecutive left ventricular ejection fraction (LVEF) ≤ 40% CIED, referred for AF, were included. Procedural parameters...
POLSKIE ARCHIWUM MEDYCYNY
The coexistence of atrial fibrillation (AF) and chronic kidney disease (CKD) increases the risk thromboembolic complications, as well hemorrhagic incidents - percutaneous left appendage occlusion (LAAO) is an alternative.To evaluate long-term outcomes LAAO performed in patients with CKD non-valvular AF.Two hundred seventy-two AF who underwent between 2009 2019 were prospectively analyzed. Patients divided into two groups: (105 patients) non-CKD (167 (cut-off point: eGFR 60 ml/min/1.73 m2)....
What's new?The results of our study clearly show that atrial fibrillation is an independent risk factor for death and cardiovascular hospitalization.Oral anticoagulation significantly reduces the in patients with de novo diagnosed AF.Thromboembolism prophylaxis still needs improvement, especially those who are at very high stroke.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Streb W, Mitręga K, Podolecki T, et al. Comparison of transesophageal and intracardiac echocardiography in guiding percutaneous left atrial appendage closure with an Amplatzer Amulet device. Advances Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(4):446-454. doi:10.5114/aic.2019.90219. APA Streb, W., Mitręga, K., Podolecki, T., Morawski, S., Szulik, M., & Jędrzejczyk-Patej, E. (2019)....
The primary aim of the study was to evaluate risk factors for ventricular fibrillation/sustained tachycardia (VF/VT) and develop score prediction VF/VT in patients with ST-segment elevation myocardial infarction (STEMI) treated invasively. secondary assess effect on mortality depending timing arrhythmia.We analyzed 4363 consecutive STEMI Among them, 163 pre-reperfusion arrhythmia were excluded from study. Group arrhythmias (VA) encompassed - those reperfusion-induced included into group VA1,...